Eli Lilly launches weight loss drug in India beating Novo Nordisk
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has launched its popular weight loss/diabetes therapy
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has launched its popular weight loss/diabetes therapy
Gunter_Nezhoda Alphabet (GOOG) (GOOGL), Mastercard (MA) and Chubb (CB) were among the least shorted S&P
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) shares snapped six straight days of losses
Noam Galai The Senate Health, Education, Labor and Pension Committee Thursday morning advanced the nomination
patty_c A recent survey found that 19% of Americans have tried a GLP-1 medication —
jetcityimage Eli Lilly appears (NYSE:LLY) to be accelerating plans to launch its portfolio of weight
choi dongsu The weight-loss drug market is evolving at a rapid speed, with leading pharma
da-kuk The U.S. stock market was down for the week despite a positive Friday, as
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) on Friday said that its recently approved
Marilyn Nieves Hims & Hers (NYSE:HIMS) fell ~8% in the premarket Thursday after a court